首页 | 本学科首页   官方微博 | 高级检索  
     


Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti
Authors:Debrah Alexander Yaw  Mand Sabine  Marfo-Debrekyei Yeboah  Batsa Linda  Pfarr Kenneth  Buttner Marcelle  Adjei Ohene  Buttner Dietrich  Hoerauf Achim
Affiliation: Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, Bonn, Germany;  Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana;  Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;  Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany;  School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
Abstract:Objective To evaluate the efficacy of doxycycline as a macrofilaricidal agent against Wuchereria bancrofti. Method In the Western Region of Ghana, 18 patients infected with W. bancrofti were recruited and treated with 200 mg doxycycline per day for 4 weeks. Seven untreated patients served as controls. Four months after doxycycline treatment, all patients received 150 μg/kg ivermectin. Patients were monitored for Wolbachia and microfilaria loads, antigenaemia and filarial dance sign (FDS). Results Four months after doxycycline treatment, cases had a significantly lower Wolbachia load than controls; and 24 months after treatment, microfilaraemia, antigenaemia and frequency of FDS were significantly lower in cases than controls. Most importantly, 4 weeks of doxycycline killed 80% of macrofilariae, which is comparable with the results of a 6‐week regimen. Circulating filarial antigenaemia and FDS were strongly correlated. Conclusion A 4‐week regimen of doxycycline seems sufficient to kill adult W. bancrofti and could be advantageous for the treatment of individual patients, e.g. in outpatient clinics.
Keywords:lymphatic filariasis    Wuchereria bancrofti    microfilaria    Wolbachia    doxycycline    filarial dance sign
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号